Ligand validation:3ZDW

EBS: 3-ETHYL-2-[(2Z)-2-(3-ETHYL-6-SULFO-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)HYDRAZINO]-6-SULFO-3H-1,3-BENZOTHIAZOL-1-IUM

EBS is a Ligand Of Interest in 3ZDW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZDW_EBS_A_1516	0%	4%	0.569	0.278	2.97	2.71	11	8	2	0	100%	0.4
4YVN_EBS_A_604	61%	6%	0.157	0.946	2.97	2.2	12	7	1	0	100%	1
1OF0_EBS_A_1518	0%	0%	0.45	0.473	5.08	7.19	20	15	4	0	100%	0.5
7AA2_EBS_B_706	73%	52%	0.137	0.966	1.1	0.78	2	-	0	0	100%	0.7406

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.